PEAK6 Group’s Integra LifeSciences IART Stock Holding History

PEAK6 Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.45M	Buy	22,466 +10,839	+93%	+$671K	0.01%	1650
2018 Q1	$643K	Buy	11,627 +6,840	+143%	+$359K	﹤0.01%	2351
2017 Q4	$229K	Sell	4,787 -1,714	-26%	-$83.9K	﹤0.01%	3063
2017 Q3	$328K	Sell	6,501 -3,054	-32%	-$157K	﹤0.01%	2895
2017 Q2	$521K	Buy	+9,555	New	+$456K	﹤0.01%	2497
2014 Q4	–	Sell	-2,642	Closed	-$54K	–	4866
2014 Q3	$54K	Buy	+2,642	New	+$52.6K	﹤0.01%	4108

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PEAK6 Group's IART Position: Q2 2018 in Review

PEAK6 Group increased its Integra LifeSciences (IART) stake by 93% in Q2 2018, buying an estimated $671K and bringing the position to 22,466 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #1650.

PEAK6 Group first reported a position in IART in Q3 2014 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold IART as of Q2 2018.

PEAK6 Group held 22,466 shares of Integra LifeSciences worth $1.45M as of Q2 2018.
PEAK6 Group bought 10,839 Integra LifeSciences shares in Q2 2018, an estimated $671K.
Integra LifeSciences made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1650 holding.
PEAK6 Group first reported a position in Integra LifeSciences in Q3 2014 and has held it in 6 quarters since.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.